Resources Contact Us Home
Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety

Image Number 13 for United States Patent #8119616.

The present invention relates to a composition comprising an inclusion complex of a cyclodextrin and quinazoline containing zinc-binding moiety based derivatives. The cyclodextrin is preferable a .beta.-cyclodextrin or a derivative thereof. The quinazolines have enhanced and unexpected properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and their use in the treatment of EGFR-TK related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.

  Recently Added Patents
Reproducible dither-noise injection
Position and orientation measurement apparatus, position and orientation measurement method, and storage medium
Imaging apparatus having selection unit to select focus detection areas
Methods for predicting cardiac toxicity
Restarting event and alert analysis after a shutdown in a distributed processing system
Petunia plant named `Bartpet001`
  Randomly Featured Patents
Sample holder for decomposition of analysis of sample materials
Athletic nose guard
Process for formylating xylene mixture
Method for preparing pyrrolidine derivatives
Fishing lure with temperature sensing and thermostatically controlled depth selection and guidance means
Control device for hybrid vehicle drive apparatus
CVD apparatus and method of using same
Method and system for effectuating network routing over primary and backup channels
Large flexible container with replaceable inner liner
Method and system for data-rate control by randomized bit-puncturing in communication systems